BESSEMER GROUP INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 244 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
+25.0%
170
+11.1%
0.00%
Q2 2023$40.0%153
+41.7%
0.00%
Q1 2023$4
-20.0%
108
-19.4%
0.00%
Q4 2022$5
-99.9%
1340.0%0.00%
Q3 2022$5,000
+25.0%
1340.0%0.00%
Q2 2022$4,0000.0%1340.0%0.00%
Q1 2022$4,000
-20.0%
134
-15.7%
0.00%
Q4 2021$5,000
-28.6%
159
-45.0%
0.00%
Q4 2020$7,000
-12.5%
289
+5.1%
0.00%
Q3 2019$8,0002750.00%
Q2 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$183,000
-33.9%
5,5000.0%0.00%0.0%
Q3 2018$277,000
-27.7%
5,500
-14.1%
0.00%0.0%
Q2 2018$383,000
-35.2%
6,400
-83.5%
0.00%
-66.7%
Q1 2016$591,000
-79.6%
38,723
-82.0%
0.00%
-81.2%
Q4 2015$2,892,000
+16.7%
215,147
+21.8%
0.02%
+14.3%
Q3 2015$2,478,000
+864.2%
176,635
+1068.2%
0.01%
+1300.0%
Q2 2015$257,00015,1200.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders